For example, one of the most common treatments for diffuse large B-cell lymphoma is R-CHOP. This combines a drug called rituximab (Riabni, Rituxan, Ruxience, Truxima) with three chemotherapy drugs ...

DelveInsight’s, “B-cell Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape.

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

clonoSEQ testing for patients with MCL is currently available for clinical use as a laboratory-developed test performed at ...

It is one of a clutch of anti-ROR1 drugs coming through development ... V as a treatment for previously untreated diffuse large B-cell lymphoma.

These other drug combinations (all a mix of monoclonal ... You can’t always prevent diffuse large B-cell lymphoma. Many of the risk factors, such as age, sex, race, and family history, are ...

In a recent article published in Nature Cancer, a multi-institutional research team led by The University of Osaka describes ...

Less than a year after purchasing private cell therapy company ImmPact Bio to help refresh its ailing CAR-T pipeline, ...

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...